Natixis’s Travere Therapeutics TVTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-163,500
| Closed | -$1.46M | – | 1153 |
|
|
2023
Q3 | $1.46M | Buy |
163,500
+28,500
| +21% | +$255K | 0.01% | 438 |
|
|
2023
Q2 | $2.07M | Buy |
135,000
+94,700
| +235% | +$1.45M | 0.02% | 408 |
|
|
2023
Q1 | $906K | Sell |
40,300
-874
| -2% | -$19.7K | 0.01% | 531 |
|
|
2022
Q4 | $866K | Sell |
41,174
-58,826
| -59% | -$1.24M | ﹤0.01% | 603 |
|
|
2022
Q3 | $2.56M | Buy |
+100,000
| New | +$2.56M | 0.01% | 518 |
|
|
2022
Q2 | – | Sell |
-65,392
| Closed | -$1.69M | – | 1261 |
|
|
2022
Q1 | $1.69M | Buy |
+65,392
| New | +$1.69M | 0.01% | 789 |
|